Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug TAK-771 aims to control rare nerve diseases in japanese patients

NCT ID NCT05084053

Ongoing Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Dec 10, 2025 · Last updated May 13, 2026 · Updated 21 times

Summary

This study tests a medicine called TAK-771 in 26 Japanese adults with two rare nerve conditions, CIDP and MMN, which cause weakness and numbness. The goal is to see if the drug can prevent relapses and improve hand strength over up to 45 months of treatment. Participants receive the drug every 2 to 4 weeks and are closely monitored for side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aichi Medical University Hospital

    Nagakute, Aichi-ken, Japan

  • Asahikawa Medical Center

    Asahikawa, Hokkaido, Japan

  • Chiba University Hospital

    Chiba, Chiba, Japan

  • Chubu Rosai Hospital

    Nagoya, Aichi-ken, Japan

  • Fujita Health University Hospital

    Toyoake, Aichi-ken, Japan

  • Higashimatsuyama Municipal Hospital

    Higashi-Matsuyama, Saitama, Japan

  • Hiroshima University Hospital

    Hiroshima, Hiroshima, Japan

  • Hyogo College of Medicine Hospital

    Nishinomiya, Hyōgo, Japan

  • Juntendo University Hospital

    Bunkyo-ku, Tokyo, Japan

  • Kansai Rosai Hospital

    Amagasaki, Hyōgo, Japan

  • Kumamoto University Hospital

    Kumamoto, Kumamoto, Japan

  • Kyushu University Hospital

    Fukuoka, Fukuoka, Japan

  • Nara Medical University Hospital

    Kashihara, Nara, Japan

  • National Center of Neurology and Psychiatry

    Kodaira, Tokyo, Japan

  • Shiga University of Medical Science Hospital

    Ōtsu, Shiga, Japan

  • St.Marianna University School of Medicine Hospital

    Kawasaki, Kanagawa, Japan

  • Toho University Omori Medical Center

    Ōta-ku, Tokyo, Japan

  • Tohoku Medical and Pharmaceutical University Hospital

    Sendai, Miyagi, Japan

  • Tokushima National Hospital

    Yoshinogawa, Tokushima, Japan

  • Tokushima University Hospital

    Tokushima, Tokushima, Japan

  • Tokyo Women's Medical University Hospital

    Shinjuku-ku, Tokyo, Japan

  • Toyama University Hospital

    Toyama, Toyama, Japan

  • Yamaguchi University Hospital

    Ube, Yamaguchi, Japan

Conditions

Explore the condition pages connected to this study.

CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) MULTIFOCAL MOTOR NEUROPATHY (MMN)